Literature DB >> 26216881

Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.

Jose M Irimia1, Vincent S Tagliabracci1, Catalina M Meyer1, Dyann M Segvich1, Anna A DePaoli-Roach1, Peter J Roach2.   

Abstract

Glycogen, the repository of glucose in many cell types, contains small amounts of covalent phosphate, of uncertain function and poorly understood metabolism. Loss-of-function mutations in the laforin gene cause the fatal neurodegenerative disorder, Lafora disease, characterized by increased glycogen phosphorylation and the formation of abnormal deposits of glycogen-like material called Lafora bodies. It is generally accepted that the phosphate is removed by the laforin phosphatase. To study the dynamics of skeletal muscle glycogen phosphorylation in vivo under physiological conditions, mice were subjected to glycogen-depleting exercise and then monitored while they resynthesized glycogen. Depletion of glycogen by exercise was associated with a substantial reduction in total glycogen phosphate and the newly resynthesized glycogen was less branched and less phosphorylated. Branching returned to normal on a time frame of days, whereas phosphorylation remained suppressed over a longer period of time. We observed no change in markers of autophagy. Exercise of 3-month-old laforin knock-out mice caused a similar depletion of glycogen but no loss of glycogen phosphate. Furthermore, remodeling of glycogen to restore the basal branching pattern was delayed in the knock-out animals. From these results, we infer that 1) laforin is responsible for glycogen dephosphorylation during exercise and acts during the cytosolic degradation of glycogen, 2) excess glycogen phosphorylation in the absence of laforin delays the normal remodeling of the branching structure, and 3) the accumulation of glycogen phosphate is a relatively slow process involving multiple cycles of glycogen synthesis-degradation, consistent with the slow onset of the symptoms of Lafora disease.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Lafora disease (Lafora progressive myoclonic epilepsy, MELF); branching; exercise; glycogen; laforin; phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 26216881      PMCID: PMC4566241          DOI: 10.1074/jbc.M115.673897

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Regulation of glucose and glycogen metabolism during and after exercise.

Authors:  Thomas E Jensen; Erik A Richter
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

2.  Quantitative assessment of human muscle glycogen granules size and number in subcellular locations during recovery from prolonged exercise.

Authors:  I Marchand; M Tarnopolsky; K B Adamo; J M Bourgeois; K Chorneyko; T E Graham
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

3.  Myoclonus epilepsy with Lafora bodies. An ultrastruc- tural and cytochemical study.

Authors:  G H Collins; R R Cowden; A H Nevis
Journal:  Arch Pathol       Date:  1968-09

4.  The presence of phosphate in glycogen.

Authors:  J D Fontana
Journal:  FEBS Lett       Date:  1980-01-01       Impact factor: 4.124

5.  Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice.

Authors:  Subramaniam Ganesh; Antonio V Delgado-Escueta; Toshiro Sakamoto; Maria Rosa Avila; Jesus Machado-Salas; Yoshinobu Hoshii; Takumi Akagi; Hiroshi Gomi; Toshimitsu Suzuki; Kenji Amano; Kishan Lal Agarwala; Yuki Hasegawa; Dong-Sheng Bai; Tokuhiro Ishihara; Tsutomu Hashikawa; Shigeyoshi Itohara; Eain M Cornford; Hiroaki Niki; Kazuhiro Yamakawa
Journal:  Hum Mol Genet       Date:  2002-05-15       Impact factor: 6.150

Review 6.  Advances in lafora progressive myoclonus epilepsy.

Authors:  Antonio V Delgado-Escueta
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 7.  Regulation of glycogen synthase in skeletal muscle during exercise.

Authors:  J N Nielsen; E A Richter
Journal:  Acta Physiol Scand       Date:  2003-08

8.  Overexpression of glycogen synthase in mouse muscle results in less branched glycogen.

Authors:  Bartholomew A Pederson; Anna G Csitkovits; Renee Simon; Jill M Schroeder; Wei Wang; Alexander V Skurat; Peter J Roach
Journal:  Biochem Biophys Res Commun       Date:  2003-06-13       Impact factor: 3.575

Review 9.  Protein tyrosine phosphatases in the human genome.

Authors:  Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

10.  Mutations in NHLRC1 cause progressive myoclonus epilepsy.

Authors:  Elayne M Chan; Edwin J Young; Leonarda Ianzano; Iulia Munteanu; Xiaochu Zhao; Constantine C Christopoulos; Giuliano Avanzini; Maurizio Elia; Cameron A Ackerley; Nebojsa J Jovic; Saeed Bohlega; Eva Andermann; Guy A Rouleau; Antonio V Delgado-Escueta; Berge A Minassian; Stephen W Scherer
Journal:  Nat Genet       Date:  2003-09-07       Impact factor: 38.330

View more
  14 in total

1.  Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Evan P Skwara; Peixiang Wang; Xiaochu Zhao; Xiao S Pan; Erin E Chown; Travis Wang; Ami M Perri; Jennifer P Y Lee; Francisco Vilaplana; Berge A Minassian; Felix Nitschke
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

Review 2.  Mechanisms for greater insulin-stimulated glucose uptake in normal and insulin-resistant skeletal muscle after acute exercise.

Authors:  Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

Review 3.  Lafora disease offers a unique window into neuronal glycogen metabolism.

Authors:  Matthew S Gentry; Joan J Guinovart; Berge A Minassian; Peter J Roach; Jose M Serratosa
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

Review 4.  Lafora disease.

Authors:  Julie Turnbull; Erica Tiberia; Pasquale Striano; Pierre Genton; Stirling Carpenter; Cameron A Ackerley; Berge A Minassian
Journal:  Epileptic Disord       Date:  2016-09-01       Impact factor: 1.819

Review 5.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

6.  Polyglucosan body structure in Lafora disease.

Authors:  M Kathryn Brewer; Jean-Luc Putaux; Alberto Rondon; Annette Uittenbogaard; Mitchell A Sullivan; Matthew S Gentry
Journal:  Carbohydr Polym       Date:  2020-04-14       Impact factor: 9.381

Review 7.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

8.  Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid.

Authors:  Silvia Nitschke; Sara Petković; Saija Ahonen; Berge A Minassian; Felix Nitschke
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

Review 9.  Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.

Authors:  M Kathryn Brewer; Matthew S Gentry
Journal:  Adv Neurobiol       Date:  2019

10.  Brain glycogen serves as a critical glucosamine cache required for protein glycosylation.

Authors:  Ramon C Sun; Lyndsay E A Young; Ronald C Bruntz; Kia H Markussen; Zhengqiu Zhou; Lindsey R Conroy; Tara R Hawkinson; Harrison A Clarke; Alexandra E Stanback; Jessica K A Macedo; Shane Emanuelle; M Kathryn Brewer; Alberto L Rondon; Annette Mestas; William C Sanders; Krishna K Mahalingan; Buyun Tang; Vimbai M Chikwana; Dyann M Segvich; Christopher J Contreras; Elizabeth J Allenger; Christine F Brainson; Lance A Johnson; Richard E Taylor; Dustin D Armstrong; Robert Shaffer; Charles J Waechter; Craig W Vander Kooi; Anna A DePaoli-Roach; Peter J Roach; Thomas D Hurley; Richard R Drake; Matthew S Gentry
Journal:  Cell Metab       Date:  2021-05-26       Impact factor: 31.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.